News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
704,727 Results
Type
Article (63150)
Company Profile (153)
Press Release (641424)
Multimedia
Podcasts (79)
Webinars (13)
Section
Business (187109)
Career Advice (2840)
Deals (34739)
Drug Delivery (115)
Drug Development (79851)
Employer Resources (165)
FDA (16319)
Job Trends (15343)
News (327650)
Policy (33032)
Tag
Academia (2878)
Academic (2)
Accelerated approval (6)
Adcomms (26)
Allergies (92)
Alliances (47687)
ALS (98)
Alzheimer's disease (1392)
Antibody-drug conjugate (ADC) (130)
Approvals (16310)
Artificial intelligence (290)
Autoimmune disease (25)
Automation (15)
Bankruptcy (327)
Best Places to Work (12062)
BIOSECURE Act (20)
Biosimilars (116)
Biotechnology (90)
Bladder cancer (81)
Brain cancer (29)
Breast cancer (295)
Cancer (2309)
Cardiovascular disease (185)
Career advice (2407)
Career pathing (34)
CAR-T (167)
Cell therapy (459)
Cervical cancer (22)
Clinical research (64975)
Collaboration (859)
Company closure (2)
Compensation (345)
Complete response letters (22)
COVID-19 (2757)
CRISPR (47)
C-suite (272)
Cystic fibrosis (104)
Data (2299)
Decentralized trials (2)
Denatured (32)
Depression (47)
Diabetes (276)
Diagnostics (6676)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (41)
Drug discovery (124)
Drug pricing (121)
Drug shortages (23)
Duchenne muscular dystrophy (94)
Earnings (67031)
Editorial (42)
Employer branding (20)
Employer resources (145)
Events (113065)
Executive appointments (784)
FDA (17726)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (792)
Gene editing (117)
Generative AI (24)
Gene therapy (316)
GLP-1 (731)
Government (5019)
Grass and pollen (6)
Guidances (148)
Healthcare (20071)
Huntington's disease (21)
IgA nephropathy (26)
Immunology and inflammation (125)
Indications (30)
Infectious disease (2911)
Inflammatory bowel disease (150)
Inflation Reduction Act (11)
Influenza (57)
Intellectual property (101)
Interviews (545)
IPO (15907)
IRA (45)
Job creations (3720)
Job search strategy (2019)
Kidney cancer (10)
Labor market (37)
Layoffs (528)
Leadership (23)
Legal (7544)
Liver cancer (75)
Lung cancer (320)
Lymphoma (150)
Machine learning (9)
Management (59)
Manufacturing (323)
MASH (72)
Medical device (13788)
Medtech (13793)
Mergers & acquisitions (19423)
Metabolic disorders (713)
Multiple sclerosis (85)
NASH (17)
Neurodegenerative disease (88)
Neuropsychiatric disorders (27)
Neuroscience (1948)
NextGen: Class of 2025 (7067)
Non-profit (4945)
Now hiring (23)
Obesity (374)
Opinion (253)
Ovarian cancer (80)
Pain (98)
Pancreatic cancer (86)
Parkinson's disease (150)
Partnered (21)
Patents (247)
Patient recruitment (118)
Peanut (49)
People (60856)
Pharmaceutical (43)
Pharmacy benefit managers (21)
Phase I (20466)
Phase II (28493)
Phase III (21090)
Pipeline (1321)
Policy (164)
Postmarket research (2644)
Preclinical (8576)
Press Release (67)
Prostate cancer (108)
Psychedelics (36)
Radiopharmaceuticals (261)
Rare diseases (389)
Real estate (6249)
Recruiting (67)
Regulatory (22704)
Reports (34)
Research institute (2559)
Resumes & cover letters (421)
Rett syndrome (5)
RNA editing (4)
RSV (43)
Schizophrenia (72)
Series A (135)
Series B (90)
Service/supplier (11)
Sickle cell disease (57)
Special edition (15)
Spinal muscular atrophy (152)
Sponsored (31)
Startups (3598)
State (1)
Stomach cancer (10)
Supply chain (65)
Tariffs (43)
The Weekly (45)
Vaccines (770)
Venture capitalists (41)
Weight loss (241)
Women's health (39)
Worklife (20)
Date
Last 7 days (926)
Last 30 days (2912)
Last 365 days (32268)
2025 (11768)
2024 (34815)
2023 (39441)
2022 (50491)
2021 (55583)
2020 (54803)
2019 (48883)
2018 (37166)
2017 (32861)
2016 (32800)
2015 (38425)
2014 (31420)
2013 (27421)
2012 (28988)
2011 (29248)
2010 (27655)
Location
Africa (980)
Alabama (60)
Alaska (7)
Arizona (203)
Arkansas (13)
Asia (41318)
Australia (7358)
California (6118)
Canada (2034)
China (543)
Colorado (271)
Connecticut (289)
Delaware (154)
Europe (94309)
Florida (920)
Georgia (222)
Hawaii (1)
Idaho (61)
Illinois (594)
India (27)
Indiana (328)
Iowa (9)
Japan (167)
Kansas (105)
Kentucky (26)
Louisiana (12)
Maine (70)
Maryland (911)
Massachusetts (4560)
Michigan (237)
Minnesota (386)
Mississippi (2)
Missouri (91)
Montana (30)
Nebraska (25)
Nevada (66)
New Hampshire (69)
New Jersey (1780)
New Mexico (30)
New York (1785)
North Carolina (1024)
North Dakota (9)
Northern California (2676)
Ohio (208)
Oklahoma (15)
Oregon (37)
Pennsylvania (1359)
Puerto Rico (13)
Rhode Island (31)
South America (1297)
South Carolina (22)
South Dakota (1)
Southern California (2311)
Tennessee (106)
Texas (911)
United States (23473)
Utah (198)
Virginia (150)
Washington D.C. (67)
Washington State (570)
West Virginia (3)
Wisconsin (64)
704,727 Results for "national institutes of health nih".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development
February 6, 2025
·
12 min read
Press Releases
Enalare Therapeutics Receives Second Component of a National Institutes of Health (NIH) Grant Award to Fund the Next Human Study of ENA-001
January 30, 2025
·
4 min read
Press Releases
NIH awards Feinstein Institutes $2 million to study impact of heat, stroke on people with Alzheimer’s disease
April 16, 2025
·
3 min read
Press Releases
Vaxxas Licenses Next-Generation Vaccine for Respiratory Syncytial Virus (RSV) from the United States National Institutes of Health (NIH)
October 28, 2024
·
6 min read
Biotech Beach
Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to Support DARE-PTB1 Phase 1 Human Clinical Study
Daré Bioscience, Inc. today announced that it received a Notice of Award of a grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a division of the National Institutes of Health (NIH).
December 13, 2023
·
10 min read
Business
The Foundation for the National Institutes of Health Names Recipients of the 2024 Charles A. Sanders, MD, Partnership Award
The Foundation for the National Institutes of Health will award the 2024 Charles A. Sanders, MD, Partnership Award to the National Institutes of Health’s National Institute of Neurological Disorders and Stroke, AbbVie, and Robert and Sarah Newcomb.
June 18, 2024
·
4 min read
Press Releases
Lactiga Secures Multi-Year, Multi-Million Dollar Grant from NIH’s National Institute of Allergy and Infectious Diseases to Advance Groundbreaking, Mucosal-Targeted Secretory IgA for Immunodeficient Patients
February 3, 2025
·
1 min read
Press Releases
Rigel’s Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease
January 23, 2025
·
10 min read
Drug Development
Daxor Corporation Awarded Support from the National Institutes of Health (NIH) Catalyze Preclinical Services Program
Daxor Corporation today announces it has been accepted into the National Institutes of Health (NIH) Catalyze Preclinical Services Program.
October 4, 2023
·
4 min read
Pharm Country
Xylyx Bio Awarded $2.26M NIH SBIR Grant from National Cancer Institute
Xylyx Bio, Inc. announced that it has been awarded a Small Business Innovation Research Fast-Track grant from the National Cancer Institute of the National Institutes of Health to advance commercial development of its InMatrico® disease modeling and drug testing platform to help scientists discover and test drug candidates for metastatic breast cancer.
June 14, 2024
·
2 min read
1 of 70,473
Next
